Adocia Company

Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field.
Industry: Metabolism Dysfunctions
Headquarters: France

Visit Website
Register and Claim Ownership